What this means
This is a planned study of a cosmetic skin product with no results yet posted. It will show whether the product works and is safe, but it cannot tell us that now.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 35–60 · 45 women aged 35 to 60, planned
- Where
- Not listed
The science
- Registered title
- Clinical Trial to Assess the Efficacy and Safety of a Cosmetic Product in Individuals Showing Signs of Cutaneous Aging.
- Trial ID
- NCT07343544 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Skin, Skin Ageing, Fine Lines, Face Aging/Photo Aging of Moderate Grade, Face Skin Photoaging
- What is tested
- Active cream
- Sponsor
- AB Biotics, SA
- Ages
- 35 Years to 60 Years
- Dates
- First posted Jan 15, 2026 · updated Jan 15, 2026
Registry summary
This clinical study investigates the effects and safety of a topical cosmetic product containing postbiotics (Bifida ferment extract and Pediococcus ferment extract) in women aged 35-60 with visible signs of skin aging.
The study is a 3-month, single-center, intra-subject controlled trial involving 45 Caucasian women with sensitive or normal skin. Participants will apply 1 ml of the product twice daily. Clinical evaluations will be conducted at baseline and at 1 month, 2 months, and 3 months, using validated dermatological scales and non-invasive instruments (AEVA3D, Mexameter®, MoistureMap®, Cutometer®, Tewameter®, Clarius®, Glossymeter®).
Safety will be assessed through systematic monitoring of adverse events, with serious adverse events expected to remain below 1%. Subjective perception will be evaluated via structured questionnaires.